Breethe
Baltimore, US · Founded 2014 · Delaware corporation
Biotech
Founders & leadership
CA
Carl A. CohenPresident
Reported raises · per SEC filings
Form D private placements$19.2M disclosed across 7 rounds · 2015–2019
▶$8MraisedJul 2019 · 24 investors · BiotechnologyRule 506(b)
▶$8MraisedJul 2019 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl A. CohenDirector
- Bartley GriffithDirector
- Steven OrwigExecutive Officer
- Donald W. FallonExecutive Officer
- Marshal LinderExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $8M
- Minimum investment
- $1
- Sales commissions
- $120K
- Placement agents
- INTE SECURITIES LLC
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedOct 2018 · 29 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2018 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marshal LinderDirector
- Michael CippelExecutive Officer
- Carl A. CohenExecutive Officer, Director
- Bartley GriffithDirector
- Offering amount
- $5M
- Amount sold
- $3.5M
- Minimum investment
- $1
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$3MraisedDec 2017 · 22 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2017 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael CippelExecutive Officer
- Carl A. CohenExecutive Officer, Director
- Marshal LinderDirector
- Bartley GriffithDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $1
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.1MraisedAug 2017 · 7 investors · BiotechnologyRule 506(b)
▶$1.1MraisedAug 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl A. CohenExecutive Officer, Director
- Michael CippelExecutive Officer
- Marshal LinderDirector
- Bartley GriffithDirector
- Offering amount
- $3.6M
- Amount sold
- $1.1M
- Minimum investment
- $1
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedAug 2016 · 20 investors · BiotechnologyRule 506(b)
▶$2.2MraisedAug 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bartley GriffithDirector
- Carl CohenExecutive Officer, Director
- Marshal LinderDirector
- Offering amount
- $3.6M
- Amount sold
- $2.2M
- Minimum investment
- $1
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$575KraisedSep 2015 · 6 investors · BiotechnologyRule 506(b)
▶$575KraisedSep 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl A. CohenExecutive Officer, Director
- Offering amount
- $650K
- Amount sold
- $575K
- Minimum investment
- $1
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$810KraisedJan 2015 · 5 investors · BiotechnologyRule 506(b)
▶$810KraisedJan 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl A. CohenExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $810K
- Minimum investment
- $1
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Breethe raised?
- Breethe has disclosed $19.2M raised across 7 rounds.
- Where is Breethe headquartered?
- Breethe is headquartered in Baltimore, US.